期刊文献+

PDE8B基因多态性与中国汉族人群高促甲状腺素血症易感性的关联分析 被引量:3

Association analysis of PDE8B gene polymorphisms with the susceptibility to hyperthyrotropinaemia in Chinese HaM population
原文传递
导出
摘要 目的研究磷酸二酯酶8B(PDE8B)基因多态性与中国汉族人群高促甲状腺素(TSH)血症的相关性。方法采用病例.对照的研究方法,用Illumina 660全基因组芯片对98例正常范围高血清TSH者(H—TSH组)及1300名健康对照者(对照组)657366个单核苷酸多态性(SNP)位点进行基因分型,并分析PDE8B基因内含子1中25个SNP位点与高TSH血症的相关性。结果在PDE8B基因内含子1中,H-TSH组5个SNP位点rs7702192_A、rs7714529_G、rs251421_T、rs12514694_A及rs10066802_G等位基因频率均显著高于对照组(49.5%比40.9%,P=0.019;91.3%比84.9%,P=0.014;90.3%比84.9%,P=0.039;37.2%比28.3%,P=0.008;50.0%比40.1%,P=0.006)。与对照组相比,H—TSH组rs7714529(X2=6.430,P:0.040)、rs12514694(Х^2=7.191,P=0.027)及rs10066802(Х^2=9.213,P=0.010)基因型分布差异均有统计学意义。5个SNP位点的单倍型AGTAG(rs7702192/rs7714529/rs251421/rs12514694/rs10066802)在H—TSH组中的分布频率显著性高于对照组(Х^2=8.41,P=0.004)。结论PDE8B基因多态性可能与中国汉族人群的高TSH血症相关,也许能为甲状腺疾病的治疗提供新的思路。 Objective To explore the correlations of the polymorphisms of phosphodiesterase 8B (PDE8B) gene with hyperthyrotropinemia in Chinese HaM population. Methods A case-control study of genotype 657 366 SNPs was performed by Illumina Human660-Quad BeadChips in 98 hyperthyrotropinemia patients and 1300 controls. And 25 SNPs within PDE8B gene intron 1 were used for association analyses. Results Allele frequencies of 5 SNPS in PDESB gene intron 1 showed significant differences between the case and control groups (P 〈 0. 05 ). In comparison with the control group, the genotypic distributions of rs7714529 (X^2 =6.430, P=0.040), rs12514694 (X^2 =7.191, P=0.027) and rs10066802 (X^2 = 9. 213, P = 0. 010 ) in H-TSH group had significant differences. Haplotype AGTAG (rs7702192/ rs7714529/rs251421/rs12514694/rs10066802) was over-represented in hyperthyrotropinemia cases versus the control group. Conclusion PDE8B gene polymorphisms may be correlated with hyperthyrotropinaemia in Chinese Hart population. And it may provide new concepts for the treatment of thyroid dysfunction.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第12期801-805,共5页 National Medical Journal of China
基金 国家自然科学基金(30971595)
关键词 高甲状腺素血症 磷酸二酯酶8B 多态性 单核苷酸 单元型 Hyperthyrotropinaemia Phosphodiesterase 8 B Polymorphism, single nucleotide Haplotypes
  • 相关文献

参考文献17

  • 1Brent GA. The molecular basis of thyroid hormone action[J].New England Journal of Medicine,1994.847-853.
  • 2Yen PM. Physiological and molecular basis of thyroid hormone action[J].Physiological Reviews,2001.1097-1142.
  • 3Bender AT,Beavo JA. Cyclic nucleotide phosphodiesterases:molecular regulation to clinical use[J].Pharmacological Reviews,2006.488-520.
  • 4Lisette AL,Gianluca U,Graziano C. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function[J].American Journal of Human Genetics,2008.1270-1280.
  • 5Baskin HJ,Cobin RH,Duick DS. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism[J].Endocrine Practice,2002.457-469.
  • 6Keffer JH. Preanalytical considerations in testing thyroid function[J].Clinical Chemistry,1996.125-134.
  • 7滕卫平.对血清促甲状腺激素正常值范围的新认识[J].中华内科杂志,2006,45(2):89-90. 被引量:30
  • 8Vanderpump MP,Tunbridge WM,French JM. The incidence of thyroid disorders in the community:a twenty-year follow-up of the Whickham Survey[J].Clinical Endocrinology(Oxford),1995.55-68.
  • 9Hansen PS,Brix TH,Sφrensen TI. Major genetic influence on the regulation of the pituitary-thyroid axis:a study of healthy Danish twins[J].Journal of Clinical Endocrinology and Metabolism,2004.1181-1187.
  • 10Samollow PB,Perez G,Kammerer CM. Genetic and environmental influences on thyroid hormone variation in Mexican Americans[J].Journal of Clinical Endocrinology and Metabolism,2004.3276-3284.

二级参考文献12

  • 1Wartofsky L,Dickey RA.The evidence for a narrower thyrotropin reference range is compelling.J Clin Endocrinol Metab,2005,90:5483-5488.
  • 2Surks MI,Goswami G,Daniels GH.The thyrotropin reference range should remain unchanged.J Clin Endocrinol Metab,2005,90:5489-5496.
  • 3Baloch Z,Carayon P,Conte-Devolx B,et al.Laboratory medicine practice guidelines.Laboratory support for the diagnosis and monitoring of thyroid disease.Thyroid,2003,13:3-126.
  • 4Vanderpump MP,Tunbridge WM,French JM,et al.The incidence of thyroid disorders in the community:a twenty-year follow-up of the Whickham survey.Clin Endocrinol(Oxf),1995,43:55-68.
  • 5American Association of Clinical Endocrinologists.American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism.Endocr Pract,2002,8:457-469.
  • 6Stathatos N,Watofsky I.Managing subclinical hypothyroidism in women.Women Health Primary Care,2002,5:239-246.
  • 7Stephens PA.The Endocrine Society:current issues in thyroid disease management.Endocr News,2004,29:23-26.
  • 8Lee SL.When is the TSH normal? New criteria for diagnosis and management.12th Annual Meeting of the American Association of Clinical Endocrinologists.San Diego:CA,2003.(thyroidtoday.com).
  • 9Haugen BR.When isn't the TSH normal and why? Clinical implications and causes.12th Annual Meeting of the American Association of Clinical Endocrinologists.San Diego:CA,2003.(thyroidtoday.com).
  • 10Haddow JE,Palmomaki GE,Allan WC,et al.Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of child.N Engl J Med,1999,341:549-555.

共引文献29

同被引文献15

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部